Wednesday, September 27, 2023 |

Novavax’s Covid vaccine up for review by CDC advisory committee

July 19, 2022

Gaithersburg’s Novavax Inc. is on the cusp of rolling out its Covid-19 vaccine to the public. But first, a Centers for Disease Control and Prevention advisory panel must review the biotech’s protein-based vaccine. That’s on the calendar for Tuesday, less than a week after the Food and Drug Administration authorized the product for emergency use in the U.S.

Article Source: Washington Business Journal

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.